Medmen Enterprises Inc Class B

Company Profile

Medmen Enterprises Inc Class B had its IPO on under the ticker symbol MMNFF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Medmen Enterprises Inc Class B has a staff strength of 428 employees.

Stock update

Shares of Medmen Enterprises Inc Class B opened at $0.03 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.03 - $0.04, and closed at $0.03.

This is a -9.38% slip from the previous day's closing price.

A total volume of 9,833,600 shares were traded at the close of the day’s session.

In the last one week, shares of Medmen Enterprises Inc Class B have increased by +16%.

Medmen Enterprises Inc Class B's Key Ratios

Medmen Enterprises Inc Class B has a market cap of $34.82 million, indicating a price to book ratio of 0.2546 and a price to sales ratio of 0.2594.

In the last 12-months Medmen Enterprises Inc Class B’s revenue was $120.12 million with a gross profit of $69.73 million and an EBITDA of $-14405852. The EBITDA ratio measures Medmen Enterprises Inc Class B's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Medmen Enterprises Inc Class B’s operating margin was -27.08% while its return on assets stood at -6.28% with a return of equity of 0%.

In Q2, Medmen Enterprises Inc Class B’s quarterly earnings growth was a positive 0% while revenue growth was a negative 22.8%.

Medmen Enterprises Inc Class B’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.14 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medmen Enterprises Inc Class B’s profitability.

Medmen Enterprises Inc Class B stock is trading at a EV to sales ratio of 2.9097 and a EV to EBITDA ratio of -3.7707. Its price to sales ratio in the trailing 12-months stood at 0.2594.

Medmen Enterprises Inc Class B stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$215.59 million

Total Liabilities

$474.28 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Medmen Enterprises Inc Class B ended 2024 with $215.59 million in total assets and $0 in total liabilities. Its intangible assets were valued at $215.59 million while shareholder equity stood at $122.36 million.

Medmen Enterprises Inc Class B ended 2024 with $28.62 million in deferred long-term liabilities, $474.28 million in other current liabilities, in common stock, $-941143491.00 in retained earnings and $0 in goodwill. Its cash balance stood at $7.63 million and cash and short-term investments were $7.63 million. The company’s total short-term debt was $298,332,971 while long-term debt stood at $0.

Medmen Enterprises Inc Class B’s total current assets stands at $91.08 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.54 million compared to accounts payable of $115.27 million and inventory worth $14.67 million.

In 2024, Medmen Enterprises Inc Class B's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Medmen Enterprises Inc Class B paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.03

52-Week High

$0.058

52-Week Low

$0.012

Analyst Target Price

$

Medmen Enterprises Inc Class B stock is currently trading at $0.03 per share. It touched a 52-week high of $0.058 and a 52-week low of $0.058. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.02 and 200-day moving average was $0.02 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 1027.6% of the company’s stock are held by insiders while 276.9% are held by institutions.